Kenkare-Mitra Sara's Form 4/A amendment
AmendedUnicycive Therapeutics, Inc. (UNCY) · filed Jun 15, 2026
- Accession no.
- 0001213900-26-068921
- Filed
- Jun 15, 2026
- Trade date
- May 14, 2026
- Filing delay
- 32 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- May 21, 2026
This filing lists 2 derivative transactions. It was filed 32 days after the trade.
This filing was later replaced by the amendment 0001213900-26-082273 (Jul 28, 2026). Trade tables on this site use the amended version.
This amendment replaces 0001213900-26-060079 (filed May 21, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kenkare-Mitra SaraCIK 0001895592 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 14, 2026 | Common Stock | AGrant or awardAcquired | +84,200 | $0.00 | $0 | 84,200 | Direct | |
| May 14, 2026 | Common Stock | AGrant or awardAcquired | +42,100 | $0.00 | $0 | 126,300 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. 11,694 shares vest upon grant and 2,339 vest monthly over 31 months beginning June 1, 2026, subject to the Reporting Person's continued service with the Issuer.
- F2
Represents grant of restricted stock units (the "Annual RSU Award") payable solely in common stock of the Issuer. 17,542 shares vest upon grant and 3,508 vest monthly over 7 months beginning June 1, 2026, subject to the Reporting Person's continued service with the Issuer.